User profiles for Jeremie Zerbit
 | Jérémie ZerbitHôpital Cochin Verified email at aphp.fr Cited by 1426 |
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
The Coronavirus disease (COVID-19) pandemic is disrupting our health environment. As
expected, studies highlighted the great susceptibility of cancer patients to COVID-19 and more …
expected, studies highlighted the great susceptibility of cancer patients to COVID-19 and more …
Patients with hematological malignancies treated with T-cell or B-cell immunotherapy remain at high risk of severe forms of COVID-19 in the omicron era
J Zerbit, M Detroit, A Meyer, J Decroocq… - Viruses, 2022 - mdpi.com
Background: Patients with hematological malignancies are at greater risk of severe COVID-19
and have been prioritized for COVID-19 vaccination. A significant proportion of them have …
and have been prioritized for COVID-19 vaccination. A significant proportion of them have …
Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia
J Zerbit, J Tamburini, L Goldwirt, J Decroocq… - Leukemia & …, 2021 - Taylor & Francis
Since the development of tyrosine kinase inhibitors (TKIs) targeting BCR/ABL1 and significantly
improved outcomes on long-term disease-free survival in Philadelphia chromosome-…
improved outcomes on long-term disease-free survival in Philadelphia chromosome-…
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
… Jérémie Zerbit, Jérémie Zerbit … Soledad Henriquez, Jérémie Zerbit, Timothée Bruel,
Amani Ouedrani, Delphine Planas, Paul Deschamps, Isabelle Staropoli, Jérôme Hadjadj …
Amani Ouedrani, Delphine Planas, Paul Deschamps, Isabelle Staropoli, Jérôme Hadjadj …
Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer
Metastatic thyroid cancers may dedifferentiate and become radioactive-iodine (RAI) resistant.
A redifferentiating effect can be observed with inhibitors of the mitogen-activated protein …
A redifferentiating effect can be observed with inhibitors of the mitogen-activated protein …
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: findings from an economic, clinical and organisational analysis
Objective The clinical benefit of pharmaceutical cares in improving the quality‐of‐care
outcomes is well demonstrated. Clinical pharmacy services are not systematically deployed in …
outcomes is well demonstrated. Clinical pharmacy services are not systematically deployed in …
Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study
Ibrutinib treatment has been shown to increase survival in patients with B cell malignancies.
Real-life data suggest a large part of discontinuations are due to toxicities, impairing …
Real-life data suggest a large part of discontinuations are due to toxicities, impairing …
Remdesivir for patients hospitalized with COVID-19 severe Pneumonia: a National Cohort Study (Remdeco-19)
J Zerbit, M Detroit, S Chevret, F Pene, CE Luyt… - Journal of Clinical …, 2022 - mdpi.com
Background. Given the rapidly evolving pandemic of COVID-19 in 2020, authorities focused
on the repurposing of available drugs to develop timely and cost-effective therapeutic …
on the repurposing of available drugs to develop timely and cost-effective therapeutic …
plasma concentrations and safety of lopinavir/ritonavir in COVID-19 patients
Background: Although the efficacy of lopinavir/ritonavir has not been proven, it has been
proposed as an off-label treatment for COVID-19. Previously, it has been reported that the …
proposed as an off-label treatment for COVID-19. Previously, it has been reported that the …
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)
Simple Summary Immunotherapy is increasingly used in lymphoma strategy. Risk-adapted
therapeutical management and set-up scores to -stratify the most vulnerable patients by risk …
therapeutical management and set-up scores to -stratify the most vulnerable patients by risk …
